Shanghai Junshi Biosciences , Ltd. Current Assets

The latest current assets for SHJBF is $5.2B as of June 2026. That compares with $4.8B in the prior-year period — up 8.8% year over year. Investors often review this figure alongside Shanghai Junshi Biosciences , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SHJBF's current assets moved from $4.8B to $5.2B — a 8.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shanghai Junshi Biosciences , Ltd.'s operating scale or balance-sheet position.

A current assets figure of $5.2B for SHJBF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SHJBF's current assets ($5.2B), review year-over-year change from $4.8B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Shanghai Junshi Biosciences , Ltd.'s current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.